Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Body composition in children receiving recombinant human growth hormone after renal transplantation

J Feber, P Cochat, J Lebl, H Krasnicanova, J Stepan, L David, P Braillon, L Bonnet, J Janda

. 1998 ; 54 (3) : 951-955.

Language English Country United States

Document type Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14042104

Grant support
IZ2786 MZ0 CEP Register

BACKGROUND: Recombinant human growth hormone (rhGH) is an anabolic hormone promoting protein synthesis in various tissues. Therefore, changes in body composition may be expected during rhGH treatment. METHODS: We studied changes in body composition during two years of rhGH treatment in 21 children after at least one year with a functioning renal transplant. The mean +/- SD age was 12.9+/-2.5 years at the start of rhGH therapy. A whole body, dual energy X-ray absorptiometry (DEXA) exam was performed before the initiation of rhGH therapy (T0), and was repeated at one and two year intervals after initiation of the therapy (T1 and T2, respectively). RESULTS: Lean body mass increased by a median of 0.48 SDS during the first year of treatment (P = 0.022), and the median increase during two years of therapy was 0.36 SDS (P = 0.061). On the contrary, the median fat body mass decreased by 2.17 SDS during the T0 to T1 period (P = 0.04) and by 1.99 SDS during the T0 to T2 period (P = 0.055). The index for fat body mass/lean body mass (FBM/LBM) decreased by a median of 5.3% during T0 to T1 (P < 0.001), however, a slower but still significant decrease by a median of 4.2% was noted at T2 (P < 0.05). Bone mass content did not change significantly during rhGH treatment. The medians in caloric and protein intakes were stable during rhGH treatment. CONCLUSION: A significant increase of lean body mass and a decrease of fat body mass was noted during rhGH therapy in children after renal transplantation.

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14042104
003      
CZ-PrNML
005      
20140220145945.0
007      
ta
008      
140114s1998 xxu f 000 0|eng||
009      
AR
035    __
$a (PubMed)9734622
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Feber, Janusz $7 xx0074204 $u Unité de Néphrologie Pédiatrique, Hôpital Edouard Herriot, Lyon, France; st and 2nd Medical Faculty, Carles University, Prague, Czech Republic
245    10
$a Body composition in children receiving recombinant human growth hormone after renal transplantation / $c J Feber, P Cochat, J Lebl, H Krasnicanova, J Stepan, L David, P Braillon, L Bonnet, J Janda
504    __
$a Literatura
520    9_
$a BACKGROUND: Recombinant human growth hormone (rhGH) is an anabolic hormone promoting protein synthesis in various tissues. Therefore, changes in body composition may be expected during rhGH treatment. METHODS: We studied changes in body composition during two years of rhGH treatment in 21 children after at least one year with a functioning renal transplant. The mean +/- SD age was 12.9+/-2.5 years at the start of rhGH therapy. A whole body, dual energy X-ray absorptiometry (DEXA) exam was performed before the initiation of rhGH therapy (T0), and was repeated at one and two year intervals after initiation of the therapy (T1 and T2, respectively). RESULTS: Lean body mass increased by a median of 0.48 SDS during the first year of treatment (P = 0.022), and the median increase during two years of therapy was 0.36 SDS (P = 0.061). On the contrary, the median fat body mass decreased by 2.17 SDS during the T0 to T1 period (P = 0.04) and by 1.99 SDS during the T0 to T2 period (P = 0.055). The index for fat body mass/lean body mass (FBM/LBM) decreased by a median of 5.3% during T0 to T1 (P < 0.001), however, a slower but still significant decrease by a median of 4.2% was noted at T2 (P < 0.05). Bone mass content did not change significantly during rhGH treatment. The medians in caloric and protein intakes were stable during rhGH treatment. CONCLUSION: A significant increase of lean body mass and a decrease of fat body mass was noted during rhGH therapy in children after renal transplantation.
590    __
$a bohemika - dle Pubmed
650    02
$a mladiství $7 D000293
650    12
$a složení těla $x účinky léků $7 D001823
650    02
$a kostní denzita $x účinky léků $7 D015519
650    02
$a dítě $7 D002648
650    12
$a růstový hormon $x farmakologie $7 D013006
650    02
$a lidé $7 D006801
650    12
$a transplantace ledvin $7 D016030
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cochat, P.
700    1_
$a Lebl, Jan, $d 1955- $7 jn19990010093 $u 1st and 2nd Medical Faculty, Carles University, Prague, Czech Republic
700    1_
$a Krásničanová, Hana, $d 1954- $7 nlk20000083887 $u 1st and 2nd Medical Faculty, Carles University, Prague, Czech Republic
700    1_
$a Štěpán, J. $7 _AN076305
700    1_
$a David, L.
700    1_
$a Braillon, P.
700    1_
$a Bonnet, L.
700    1_
$a Janda, Jan, $d 1941- $7 jk01050837 $u 1st and 2nd Medical Faculty, Charles University, Prague, Czech Republic
773    0_
$t Kidney International $x 0085-2538 $g Roč. 54, č. 3 (1998), s. 951-955 $p Kidney Int $w MED00010141
773    0_
$p Kidney Int $g 54(3):951-5, 1998 Sep $x 0085-2538
910    __
$a ABA008 $b B 1422 $y 4 $z 0
990    __
$a 20140114093422 $b ABA008
991    __
$a 20140220150753 $b ABA008
999    __
$a ok $b bmc $g 1006739 $s 840625
BAS    __
$a 3
BMC    __
$a 1998 $b 54 $c 3 $d 951-955 $i 0085-2538 $m Kidney international $x MED00010141 $n Kidney Int
GRA    __
$a IZ2786 $p MZ0
LZP    __
$c NLK108 $d 20140220 $a 2014-01/išbo

Find record

Citation metrics

Archiving options